Crossmark

CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation

Crossref DOI link: https://doi.org/10.1186/s40644-019-0197-5

Published Online: 2019-02-27

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shan, Quan-yuan https://orcid.org/0000-0003-0113-8020
Hu, Hang-tong https://orcid.org/0000-0002-5361-233X
Feng, Shi-ting

Peng, Zhen-peng

Chen, Shu-ling

Zhou, Qian

Li, Xin

Xie, Xiao-yan https://orcid.org/0000-0002-9761-9525
Lu, Ming-de https://orcid.org/0000-0002-9771-8144
Wang, Wei https://orcid.org/0000-0002-9485-583X
Kuang, Ming https://orcid.org/0000-0002-7397-5779
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81701701)

National Natural Science Foundation of Chin (81701719)

Natural Science Foundation of Guangdong Province (2017A030313661)

Natural Science Foundation of Guangdong Province (2017A020215195)
License Information

Text and Data Mining valid from 2019-02-27
More Information

Article History

Received: 20 November 2018

Accepted: 17 February 2019

First Online: 27 February 2019

Ethics approval and consent to participate

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

: Written informed consent for publication was obtained from all participants.

: The authors declare that they have no competing financial interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below